Osiris Therapeutics, Inc. (NASDAQ:OSIR)

CAPS Rating: 1 out of 5

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.

Recs

0
Player Avatar Brian7992 (< 20) Submitted: 8/20/2009 7:40:30 AM : Outperform Start Price: $11.70 OSIR Score: -78.94

Best Bio Bets

Featured Broker Partners


Advertisement